Analyst Reaffirms Bullish Stance on Astral
ICICI Securities has issued a research report reaffirming its BUY recommendation on Astral Ltd, while revising its sum-of-the-parts (SoTP) target price upwards to INR 1,831. This represents an increase from the previous target of INR 1,783, with the new target rolled over to September 2027 estimates.
The brokerage’s conviction remains unchanged following a recent meeting with Astral’s management, where key operational and financial insights were shared regarding the company’s trajectory for the current fiscal year.
Pipe Segment Shows Resilience and Margin Support
A significant portion of the positive outlook is driven by the company’s core pipe business. According to the report, pipe demand in the first quarter of FY27 (Q2FY27-TD) has been healthy. Astral is currently on track to achieve its guidance of double-digit volume growth for the full fiscal year 2027.
Furthermore, the company is benefiting from margin tailwinds in the pipe segment. ICICI Securities notes that higher PVC prices are contributing to improved margins. Management has expressed confidence in achieving its Operating Profit Margin (OPM) guidance of 16–18% for FY27.
Strategic Expansion in CPVC Resin
A key future catalyst highlighted in the report is the progress of Astral’s CPVC resin plant. The facility is on track to begin commercial production in Q4FY27. Once operational, this plant is expected to augment production volumes and improve the margin outlook for the pipe segment starting from FY28. This vertical integration move is seen as a strategic step to secure supply and enhance profitability in the long term.
Adhesive Business Maintains Growth Trajectory
Beyond pipes, Astral’s adhesive business in India continues to show strong traction. Despite high volatility in raw material costs, the segment is on track to meet its FY27 revenue growth guidance of 15–20%. This indicates that the company is effectively managing cost pressures while sustaining demand in this line of business.
Investment Outlook
ICICI Securities maintains its BUY rating based on these operational updates and financial projections. The raised target price reflects the brokerage’s confidence in Astral’s ability to deliver on its volume and margin targets, supported by upcoming capacity additions in the CPVC segment.
